Novavax, Inc.
NVAX
$5.96
-$0.23-3.72%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 654.89% | 4.50% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 654.89% | 4.50% | |||
| Cost of Revenue | -13.82% | -18.86% | |||
| Gross Profit | 1,902.38% | 50.26% | |||
| SG&A Expenses | -35.11% | 9.55% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -29.54% | -0.25% | |||
| Operating Income | 511.23% | 3.34% | |||
| Income Before Tax | 806.49% | 39.85% | |||
| Income Tax Expenses | -83.89% | 821.80% | |||
| Earnings from Continuing Operations | 740.07% | 33.20% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 740.07% | 33.20% | |||
| EBIT | 511.23% | 3.34% | |||
| EBITDA | 564.18% | 3.55% | |||
| EPS Basic | 736.82% | 33.28% | |||
| Normalized Basic EPS | 531.68% | -1.41% | |||
| EPS Diluted | 680.32% | 33.28% | |||
| Normalized Diluted EPS | 491.39% | -1.41% | |||
| Average Basic Shares Outstanding | 0.50% | 0.12% | |||
| Average Diluted Shares Outstanding | 10.85% | 0.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||